Association analysis of the GDNF gene with methamphetamine use disorder in a Japanese population

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jul 1;35(5):1268-72. doi: 10.1016/j.pnpbp.2011.04.003. Epub 2011 Apr 14.

Abstract

Methamphetamine (MAP) dependence is a highly heritable and aberrant dopaminergic signaling that has been implicated in the disease. Glial cell line-derived neurotrophic factor (GDNF), which plays an important role in the survival of dopaminergic neurons, may be involved in this disorder. In this study, we examined the association between GDNF and MAP dependence using a Japanese population-based sample. We selected eight single nucleotide polymorphisms (SNPs) in the GDNF locus for the association analysis. When patients with MAP dependence were divided into two subgroups consisting of multi-substance and MAP-only users, we detected a significant association between these two groups and the tagging SNP, rs2910704 (after Bonferroni's correction; allele P=0.034). Thus, GDNF is likely to be related to the severity of MAP use in the Japanese population.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles
  • Amphetamine-Related Disorders / epidemiology
  • Amphetamine-Related Disorders / genetics*
  • Asian People / ethnology
  • Asian People / genetics*
  • Dopamine / genetics
  • Female
  • Gene Frequency
  • Genetic Predisposition to Disease
  • Genotype
  • Glial Cell Line-Derived Neurotrophic Factor / genetics*
  • Glial Cell Line-Derived Neurotrophic Factor / metabolism
  • Humans
  • Japan / epidemiology
  • Linkage Disequilibrium
  • Male
  • Polymorphism, Single Nucleotide / physiology
  • Sequence Tagged Sites
  • Signal Transduction / physiology

Substances

  • Glial Cell Line-Derived Neurotrophic Factor
  • Dopamine